Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1971 1
1972 4
1973 1
1974 2
1975 5
1977 1
1978 1
1979 1
1986 3
1988 1
1989 2
1990 2
1991 1
1992 2
1993 1
1994 1
1996 2
1999 2
2000 3
2001 4
2002 13
2003 4
2004 11
2005 10
2006 18
2007 12
2008 12
2009 15
2010 12
2011 14
2012 25
2013 28
2014 21
2015 29
2016 16
2017 24
2018 21
2019 15
2020 21
2021 14
2022 12
2023 15
2024 18
2025 13
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

389 results

Results by year

Filters applied: . Clear all
Page 1
Carboplatin plus etoposide versus topotecan as second-line treatment for patients with sensitive relapsed small-cell lung cancer: an open-label, multicentre, randomised, phase 3 trial.
Baize N, Monnet I, Greillier L, Geier M, Lena H, Janicot H, Vergnenegre A, Crequit J, Lamy R, Auliac JB, Letreut J, Le Caer H, Gervais R, Dansin E, Madroszyk A, Renault PA, Le Garff G, Falchero L, Berard H, Schott R, Saulnier P, Chouaid C; Groupe Français de Pneumo-Cancérologie 01–13 investigators. Baize N, et al. Among authors: geier m. Lancet Oncol. 2020 Sep;21(9):1224-1233. doi: 10.1016/S1470-2045(20)30461-7. Lancet Oncol. 2020. PMID: 32888454 Clinical Trial.
Rubella vaccination.
Geier MR. Geier MR. Fertil Steril. 1992 Jan;57(1):229. doi: 10.1016/s0015-0282(16)54810-9. Fertil Steril. 1992. PMID: 1730324 Free article. No abstract available.
Nivolumab plus ipilimumab versus carboplatin-based doublet as first-line treatment for patients with advanced non-small-cell lung cancer aged ≥70 years or with an ECOG performance status of 2 (GFPC 08-2015 ENERGY): a randomised, open-label, phase 3 study.
Léna H, Greillier L, Cropet C, Bylicki O, Monnet I, Audigier-Valette C, Falchero L, Vergnenègre A, Demontrond P, Geier M, Guisier F, Hominal S, Locher C, Corre R, Chouaid C, Ricordel C; GFPC 08–2015 ENERGY investigators. Léna H, et al. Among authors: geier m. Lancet Respir Med. 2025 Feb;13(2):141-152. doi: 10.1016/S2213-2600(24)00264-9. Epub 2024 Oct 29. Lancet Respir Med. 2025. PMID: 39486424 Clinical Trial.
Human Enzymes for Organic Synthesis.
Winkler M, Geier M, Hanlon SP, Nidetzky B, Glieder A. Winkler M, et al. Among authors: geier m. Angew Chem Int Ed Engl. 2018 Oct 8;57(41):13406-13423. doi: 10.1002/anie.201800678. Epub 2018 Sep 11. Angew Chem Int Ed Engl. 2018. PMID: 29600541 Free PMC article. Review.
Safety and efficacy of second-line metronomic oral vinorelbine-atezolizumab combination in stage IV non-small-cell lung cancer: An open-label phase II trial (VinMetAtezo).
Vergnenegre A, Monnet I, Ricordel C, Bizieux A, Curcio H, Bernardi M, Corre R, Guisier F, Hominal S, Le Garff G, Bylicki O, Locher C, Geier M, Chouaïd C, Robinet G; GFPC team. Vergnenegre A, et al. Among authors: geier m. Lung Cancer. 2023 Apr;178:191-197. doi: 10.1016/j.lungcan.2023.02.020. Epub 2023 Feb 27. Lung Cancer. 2023. PMID: 36868180 Clinical Trial.
A critique that misses the mark.
Geier DA, Kern JK, Homme KG, Geier MR. Geier DA, et al. Among authors: geier mr. Int J Hyg Environ Health. 2019 Mar;222(2):309-310. doi: 10.1016/j.ijheh.2018.11.006. Int J Hyg Environ Health. 2019. PMID: 30850066 No abstract available.
389 results